Leclercia adecarboxylata in a Patient With Newly Diagnosed Chronic Lymphocytic Leukemia

Nivedha Balaji1, Aarushi Kalra1, Aleksandra Ignatowicz1

  • 1Internal Medicine, Northeast Georgia Medical Center Gainsville, Gainesville, USA.

Cureus
|May 13, 2024
PubMed

Insights

Leclercia adecarboxylata bacteremia is a rare infection in immunocompromised patients, often mistaken for E. coli. This opportunistic pathogen is treatable with common antibiotics.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases

Background:

  • Leclercia adecarboxylata is a Gram-negative bacillus.
  • It is frequently misidentified as Escherichia coli.
  • This opportunistic pathogen resides in aquatic environments.

Observation:

  • Immunocompromised individuals are commonly affected.
  • A case of a 53-year-old immunocompromised male patient is presented.
  • The patient was managed for Leclercia adecarboxylata bacteremia.

Findings:

  • Leclercia adecarboxylata presents as a nonfatal infection with low virulence.
  • The bacterium shows susceptibility to numerous common antibiotics.
  • Accurate identification is crucial to avoid misdiagnosis as E. coli.

Implications:

  • Early and accurate diagnosis of L. adecarboxylata is essential for appropriate treatment.
  • Understanding its opportunistic nature aids in managing infections in immunocompromised hosts.
  • This case highlights the importance of considering L. adecarboxylata in the differential diagnosis of Gram-negative bacteremia.